PrintThe Burrill Report
The Burrill Report (November 25, 2013): A Common Ground for Discussing Healthcare (.MP3,17.94 Mb)
The discussion of healthcare reform in the United States is often shaded by partisan politics and the difficulties of grappling with its complexity, but a recent Special Communication in the Journal of the American Medical Association seeks to provide a common basis for discussion. We spoke to lead author Hamilton Moses III of the Alerion Institute and the Johns Hopkins School of Medicine about the paper, the competing interests at play in healthcare, and some of the implications for innovative drugs and devices.
November 21, 2013
http://www.burrillreport.com/article-a_common_ground_for_discussing_healthcare.html
HEALTHCARE REFORM
A Common Ground for
Discussing Healthcare
[Please login to post comments]
- Comparative Effectiveness Studies of Cancer Drugs Is Costly
NCI researchers say high cost of some drugs makes it difficult to assess them against cheaper treatments. Read More - Pfizer and AstraZeneca Team with Cancer Research UK to Advance Personalized Medicine
Researchers will have access to pharmas’ drug libraries, testing several drugs at same time in lung cancer trial. Read More - Privately Held Life Sciences Companies Raise $1.5B so Far in April
Biotechs rake in $188 million in series B cash in short week before Easter. Read More - The Rise in Drug Spending and What It Means
Podcast: April 21, 2014 Read More - Scripps Initiative Nabs J&J; Innovation as First Collaborator
Program aims to translate promising early-stage research into clinical candidates. Read More - HHS Secretary Sebelius Resigns
Read More - Biotech IPOs Cool Amid Market Jitters
As public market enthusiasm wavers, companies going public face tougher terms. Read More - Mallinckrodt To Buy Questcor for $5.6 Billion
Deal adds high-value specialty drug to pharma’s growing pipeline. Read More - Study Highlights Opportunities to Reduce Spending on Costly Specialty Drugs
New report says payers could benefit by transitioning specialty medications from the medical to the pharmacy benefit. Read More - Personalizing Cancer Therapies with a Mouse
Podcast: April 14, 2014 Read More
.gif)
